Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Safety of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis: Comparison of Global ENHANCE to PROWES — Richard Beale (2003) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Safety of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis: Comparison of Global ENHANCE to PROWES
Shared by
Jean Louis Vincent
Université Libre de Bruxelles
Safety of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis: Comparison of Global ENHANCE to PROWES
Article
2003
en
Authors
+2 more
RB
Richard Beale
TW
Theressa J. Wright
KW
Kar Wong
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2003
Global ENHANCE Results Indicate Organ Function Improvement With Drotrecogin Alfa (activated) in Severe Sepsis Patient
Jean Louis Vincent
,
Bruce Light
,
Theressa J. Wright
,
Kar Wong
,
Gerald D. Johnson
,
Gordon R. Bernard
Article
2003
Baseline Characteristics and Survival of Adult Severe Sepsis Patients Treated With Drotrecogin Alfa (Activated) in a Global, Single-Arm, Open-Label Trial (ENHANCE
Arthur P. Wheeler
,
Christopher Doig
,
Theressa J. Wright
,
Kar Wong
,
Jean Louis Vincent
,
Gordon R. Bernard
Article
2004
The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
Jean Louis Vincent
,
Gordon R. Bernard
,
Jean François Dhainaut
,
Mitchell M. Levy
,
Arthur P. Wheeler
,
William L. Macias
Article
2006
Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis
Daniel De Backer
,
Colin Verdant
,
Marialuisa Chierego
,
Marc Koch
,
Antonino Gullo
,
Jean Louis Vincent
Article
2006
Drotrecogin alfa (activated) in the treatment of severe sepsis
Jean Louis Vincent
Discussion(0)
No comments yet. Be the first to comment.